TSO3 Inc. (TOS.TO)
-Toronto 0.55 
0.13(19.12%) 2:27PM EDT
| Prev Close: | 0.68 |
|---|
| Open: | 0.65 |
|---|
| Bid: | 0.55 |
|---|
| Ask: | 0.56 |
|---|
| 1y Target Est: | 2.06 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | 7-Aug-13 |
|---|
| Day's Range: | 0.51 - 0.65 |
|---|
| 52wk Range: | 0.51 - 1.40 |
|---|
| Volume: | 467,175 |
|---|
| Avg Vol (3m): | 46,909 |
|---|
| Market Cap: | 40.09M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in CAD.
Headlines
- IIROC Trade Resumption - TOSCNW Group(Wed 8:42AM EDT)
- TSO3 to evaluate strategic alternatives in parallel with US regulatory approval processCNW Group(Tue, Jun 18)
- IIROC Trading Halt - TOS (all issues)CNW Group(Tue, Jun 18)
- Canaccord Genuity Updates Coverage on TSO3 Inc. (TSX:TOS) - Video Posted on InvestmentPitch.comThomson Reuters ONE(Tue, May 14)
- TSO3 announces the results of the vote for the election of the members of the Board of DirectorsCNW Group(Thu, May 9)
- Q1 2013 TSO3 INC Earnings Release - Before Market OpenCCBN(Wed, May 8)
- TSO3 to Hold Annual and Special Meeting of Shareholders TodayCNW Group(Wed, May 8)
- TSO3 announces financial results for first quarter 2013CNW Group(Wed, May 8)
- TSO3 to Disclose First Quarter 2013 Financial Results and Hold Annual General Meeting of Shareholders May 8, 2013CNW Group(Mon, Apr 29)
- US Regulatory Agency provides favorable review and recommends path for approval - TSO3 to pursue de novo Process ClassificationCNW Group(Wed, Apr 17)
- TSO3 appoints Claude Michaud and Jean Lamarre to the Board of DirectorsCNW Group(Wed, Mar 20)
- TSO3 discloses fourth quarter and full year 2012 fiscal resultsCNW Group(Wed, Mar 20)
- Q4 2012 TSO3 INC Earnings Release - Before Market OpenCCBN(Wed, Mar 20)
- /R E P E A T -- TSO3: conference call and webcast for the 2012 annual financial results/CNW Group(Wed, Mar 20)
- TSO3: conference call and webcast for the 2012 annual financial resultsCNW Group(Thu, Mar 7)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 23.06 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.10 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.03 |
|---|
| Mean Recommendation*: | 1.8 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
TSO3 Inc. engages in the research, development, commercialization, and licensing of sterilization processes and accessories for heat-sensitive medical devices.
View More